Medicine
At ZYRAX, we recognize that many animals suffering from chronic inflammatory conditions only have access to therapies that manage symptoms rather than address the underlying causes. We are committed to targeting the molecular origins of these debilitating diseases, aiming to deliver more effective treatments for pets, livestock, and wildlife.

Understanding Inflammation in Animals
Inflammation is a natural immune response to injury or infection. However, in autoimmune diseases and chronic inflammatory conditions like rheumatoid arthritis, colitis, and allergic reactions, an animal’s immune system attacks its own tissues. These conditions can be painful and severely impact the quality of life for both pets and farm animals.

Existing therapies often only offer temporary symptom relief. For decades, veterinarians have relied on anti-inflammatory medications like steroids, which, while effective, can have harmful long-term side effects. Now, with advancements in veterinary science, we have the potential to transform the management of inflammatory diseases by targeting specific molecular pathways.

Advancing Treatment Options for Chronic Inflammation
Through continued research, we can now focus on developing therapies that do more than suppress inflammation broadly. We are advancing treatments that target key proteins and pathways involved in chronic inflammation, offering more precise and effective solutions for animals living with autoimmune and inflammatory diseases.

At ZYRAX, we are particularly focused on evolving treatments beyond general immunosuppression. Our research is centered on therapies that selectively modulate the immune system, enabling animals to thrive while minimizing side effects and improving long-term health.

Innovation in Immune System Health
Emerging approaches are focused on restoring immune system balance and promoting tissue healing. Our team is dedicated to exploring new treatments that go beyond symptom management to deliver true cures. Precision medicine is integral to our approach, ensuring that therapies are tailored to the individual animal, maximizing the effectiveness of treatments based on disease biology.

Key Areas of Focus
We are targeting specific inflammatory conditions that affect animals, including:

• Arthritis & Joint Inflammation: Exploring therapies for conditions like osteoarthritis in pets and livestock.
• Gastrointestinal Diseases: Investigating treatments for conditions like colitis and inflammatory bowel diseases.
• Skin Inflammation: Developing targeted therapies for inflammatory skin disorders in companion animals.

Emerging Technologies and Approaches
We are utilizing cutting-edge technologies such as Janus kinase (JAK) inhibitors, which offer a new frontier in treating autoimmune and inflammatory diseases. Our research aims to develop tailored therapies for conditions like arthritis, allergies, and inflammatory bowel disease in animals.

Additionally, our team is exploring immune tolerance as a new therapeutic strategy. Instead of broadly suppressing the immune system, we focus on restoring self-tolerance, allowing the animal’s immune system to regulate itself without the risk of over-suppression.

Data-Driven Insights
At ZYRAX, we gather and analyze vast amounts of data from clinical studies and laboratory experiments. By leveraging advanced analytics, we identify which pathways and treatment targets offer the best potential for improving animal health. This data-driven approach enables us to develop more precise and effective treatments for chronic inflammation and autoimmune diseases.

Collaborations for Advancing Veterinary Research
We believe that collaboration is key to accelerating innovation in veterinary medicine. ZYRAX partners with leading research institutions and companies to explore genetic factors and better understand how diseases affect animals. By combining our expertise with that of others in the field, we aim to bring transformative treatments to market faster, improving the lives of animals and their caregivers.

At ZYRAX, we are dedicated to revolutionizing veterinary medicine by addressing the root causes of chronic inflammation and autoimmune diseases. Our innovative therapies are designed to enhance the quality of life for animals while minimizing the risk of side effects and promoting long-term health.